table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2030)
1.4.2 East Asia Market States and Outlook (2023-2030)
1.4.3 Europe Market States and Outlook (2023-2030)
1.4.4 South Asia Market States and Outlook (2023-2030)
1.4.5 Southeast Asia Market States and Outlook (2023-2030)
1.4.6 Middle East Market States and Outlook (2023-2030)
1.4.7 Africa Market States and Outlook (2023-2030)
1.4.8 Oceania Market States and Outlook (2023-2030)
1.4.9 South America Market States and Outlook (2023-2030)
1.5 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2030
1.5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2030 by Consumption Volume
1.5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Analysis from 2023 to 2030 by Value
1.5.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Price Trends Analysis from 2023 to 2030
1.6 COVID-19 Outbreak: Point-of-Care Infectious Disease Diagnostics/Testing Industry Impact
Chapter 2 Global Point-of-Care Infectious Disease Diagnostics/Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing (Volume and Value) by Type
2.1.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Type (2017-2022)
2.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Type (2017-2022)
2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing (Volume and Value) by Application
2.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Application (2017-2022)
2.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Application (2017-2022)
2.3 Global Point-of-Care Infectious Disease Diagnostics/Testing (Volume and Value) by Regions
2.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Regions (2017-2022)
4.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
4.10 South America Point-of-Care Infectious Disease Diagnostics/Testing Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
5.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
5.1.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
5.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
5.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
5.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
5.4.1 United States Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
5.4.2 Canada Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
5.4.3 Mexico Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 6 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
6.1 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
6.1.1 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
6.2 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
6.3 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
6.4 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
6.4.1 China Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
6.4.2 Japan Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
6.4.3 South Korea Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 7 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
7.1.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
7.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
7.4.1 Germany Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.2 UK Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.3 France Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.4 Italy Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.5 Russia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.6 Spain Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.7 Netherlands Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.8 Switzerland Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
7.4.9 Poland Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 8 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
8.1 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
8.1.1 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
8.2 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
8.3 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
8.4 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
8.4.1 India Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
8.4.2 Pakistan Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
9.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
9.1.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
9.2 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
9.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
9.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
9.4.1 Indonesia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.2 Thailand Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.3 Singapore Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.4 Malaysia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.5 Philippines Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.6 Vietnam Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
9.4.7 Myanmar Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 10 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
10.1 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
10.1.1 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
10.2 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
10.3 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
10.4 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
10.4.1 Turkey Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.3 Iran Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.5 Israel Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.6 Iraq Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.7 Qatar Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.8 Kuwait Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
10.4.9 Oman Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 11 Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
11.1 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
11.1.1 Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
11.2 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
11.3 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
11.4 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
11.4.1 Nigeria Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.2 South Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.3 Egypt Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.4 Algeria Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
11.4.5 Morocco Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 12 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
12.1 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
12.2 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
12.3 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
12.4 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption by Top Countries
12.4.1 Australia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
12.4.2 New Zealand Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 13 South America Point-of-Care Infectious Disease Diagnostics/Testing Market Analysis
13.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption and Value Analysis
13.1.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Market Under COVID-19
13.2 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Types
13.3 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Structure by Application
13.4 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume by Major Countries
13.4.1 Brazil Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.2 Argentina Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.3 Columbia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.4 Chile Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.5 Venezuela Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.6 Peru Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
13.4.8 Ecuador Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Point-of-Care Infectious Disease Diagnostics/Testing Business
14.1 Alere
14.1.1 Alere Company Profile
14.1.2 Alere Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.1.3 Alere Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Thermo Fisher Scientific Inc
14.2.1 Thermo Fisher Scientific Inc Company Profile
14.2.2 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 F. Hoffmann-La Roche Ltd
14.3.1 F. Hoffmann-La Roche Ltd Company Profile
14.3.2 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Siemens Healthineers
14.4.1 Siemens Healthineers Company Profile
14.4.2 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 BD & Company
14.5.1 BD & Company Company Profile
14.5.2 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Chembio Diagnostics Inc.
14.6.1 Chembio Diagnostics Inc. Company Profile
14.6.2 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Trinity Biotech
14.7.1 Trinity Biotech Company Profile
14.7.2 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Cardinal Health
14.8.1 Cardinal Health Company Profile
14.8.2 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Quest Diagnostics Inc.
14.9.1 Quest Diagnostics Inc. Company Profile
14.9.2 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Bio-Rad Labs Inc.
14.10.1 Bio-Rad Labs Inc. Company Profile
14.10.2 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 bioM?rieux SA
14.11.1 bioM?rieux SA Company Profile
14.11.2 bioM?rieux SA Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.11.3 bioM?rieux SA Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Sight Diagnostics Ltd.
14.12.1 Sight Diagnostics Ltd. Company Profile
14.12.2 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Gene POC
14.13.1 Gene POC Company Profile
14.13.2 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Trivitron Healthcare
14.14.1 Trivitron Healthcare Company Profile
14.14.2 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 OJ-Bio Ltd.
14.15.1 OJ-Bio Ltd. Company Profile
14.15.2 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Ortho-Clinical Diagnostics
14.16.1 Ortho-Clinical Diagnostics Company Profile
14.16.2 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Product Specification
14.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast (2023-2030)
15.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Price Forecast (2023-2030)
15.1.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume and Growth Rate Forecast (2023-2030)
15.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Value and Growth Rate Forecast (2023-2030)
15.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2030)
15.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume and Growth Rate Forecast by Regions (2023-2030)
15.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Value and Growth Rate Forecast by Regions (2023-2030)
15.2.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.4 East Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.5 Europe Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.6 South Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.7 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.8 Middle East Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.9 Africa Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.10 Oceania Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.11 South America Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume, Revenue and Price Forecast by Type (2023-2030)
15.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Forecast by Type (2023-2030)
15.3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Type (2023-2030)
15.3.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Price Forecast by Type (2023-2030)
15.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Consumption Volume Forecast by Application (2023-2030)
15.5 Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
